Project Grant R01HL172869

Award Date 5/15/24
Completion Date 4/30/29
Dollars Obligated $1.9M
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Providence, RI 02906, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $727,080 in funding to the University of South Carolina to conduct research on the neurogenic mechanisms underlying psychosocial stress-induced postpartum cardiovascular disease and postpartum depression. The key objectives of the research are to determine if direct stabilization of mitochondrial function in the medial...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $696,470 to the University of Denver to investigate the link between prenatal maternal sleep patterns and cardiovascular disease risk in offspring. The research aims to examine three key pathways through which prenatal maternal sleep may influence offspring cardiovascular health:...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $103,948 to the University of Denver to investigate associations between discrimination experienced during pregnancy and later maternal cardiovascular disease (CVD) risk. The 2-year study aims to: 1) test whether greater discrimination during pregnancy is associated with greater overall maternal CVD risk at 3-4 years postpartum, 2) assess...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $708,794 to the University of Pittsburgh to conduct research on identifying optimal dietary patterns for postpartum cardiovascular disease prevention. The key objectives are to: 1) Estimate the effect of longitudinal dietary patterns on postpartum risk of hypertension, metabolic syndrome, and related risk factors, while exploring...
This Project Grant award of $670,890.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, supports research to determine the vascular and neural effects of chronic lower leg heating in obese pregnant women. The primary goals are to evaluate the impact of this intervention on improving vascular endothelial function and attenuating sympathetic vasoconstriction, with the aim of reducing the risk of hypertensive disorders of...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a $502,069 research project to examine the role of the urban/rural divide and socioeconomic factors on the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The key objectives are to: 1) Determine if socioeconomic status (SES) moderates the relationship between urban/rural status and HDP...
This federal Project Grant award for $632,110 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) is focused on reducing the risk of chronic hypertension and improving vascular function following preeclampsia. The project aims to investigate the mechanisms behind the increased risk of cardiovascular disease in patients who have experienced hypertensive disorders of pregnancy, specifically examining vascular...
The federal Project Grant award R01HL165467, funded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), supports a 4-year, $127,959 research project at Colorado State University (CSU) focused on studying the role of maternal obesity, gut microbiome, and inflammation in the development of preeclampsia and fetal programming of cardiometabolic disease. The overarching goal is to test the hypothesis that maternal...
This K01 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $175,647 to the University of Pittsburgh to study biobehavioral markers of prenatal resilience associated with positive postpartum maternal mental health and well-being. The key objectives are to: 1) examine how positive childhood experiences (e.g., positive parenting, supportive peer relations) relate to physiological and psychological...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a $2,428,701 prospective study to evaluate factors associated with adverse outcomes in 1,000 pregnant individuals with cardiovascular disease. The study, conducted by the University of Missouri at Kansas City (UMKC), will assess clinical, patient-reported, and structural characteristics of care that impact maternal adverse cardiac...

MECHANISMS OF MINDFULNESS TRAINING TO REDUCE MATERNAL AND INFANT CARDIOVASCULAR DISEASE RISK - ABSTRACT HYPERTENSIVE DISORDERS OF PREGNANCY ARE THE MOST COMMON MEDICAL CONDITION AFFECTING PREGNANCY AND A LEADING CAUSE OF MATERNAL MORBIDITY AND MORTALITY IN THE UNITES STATES. FIFTY PERCENT OF WOMEN WITH PRENATAL HYPERTENSIVE DISORDERS WILL CONTINUE TO EXPERIENCE HYPERTENSION IN THE POSTPARTUM PERIOD. MORE THAN HALF OF ALL PREGNANCY-RELATED DEATHS OCCUR IN THE POSTPARTUM PERIOD, AND OVER 30% OF MATERNAL DEATHS ARE COMPLICATED BY HYPERTENSIVE DISORDERS. CONSEQUENCES OF HYPERTENSIVE DISORDERS EXTEND WELL PAST THE PERINATAL PERIOD; WOMEN WITH PRENATAL HYPERTENSIVE DISORDERS ARE TWICE AS LIKELY TO DEVELOP HEART DISEASE IN THEIR LIFETIME, AND OFFSPRING EXPOSED TO HYPERTENSIVE DISORDERS IN UTERO FACE SIGNIFICANT LIFETIME CARDIOVASCULAR DISEASE RISK. THEREFORE, PREVENTION OF PRENATAL HYPERTENSIVE DISORDERS IS CRITICAL TO REDUCING RISK FOR POSTPARTUM OBSTETRIC COMPLICATIONS AND LIFELONG CARDIOVASCULAR DISEASE. MINDFULNESS-BASED INTERVENTIONS HOLD SIGNIFICANT PROMISE AS A NON- PHARMACOLOGICAL INTERVENTION TO PREVENT THESE DISORDERS AS MINDFULNESS-BASED INTERVENTIONS REDUCE BLOOD PRESSURE IN ADULTS WITH HYPERTENSION AND PREHYPERTENSION, AND RESULTS FROM OUR PILOT RCT INDICATING THAT PRENATAL MINDFULNESS TRAINING WAS ASSOCIATED WITH REDUCED BLOOD PRESSURE AND RISK FOR HYPERTENSIVE DISORDERS IN AT-RISK WOMEN. NOW, OUR TEAM IS CONDUCTING A 5-YEAR RCT INVESTIGATING THE DAILY MECHANISMS OF PRENATAL MINDFULNESS TRAINING ON PRENATAL MARKERS OF CARDIOVASCULAR RISK (R01HL157288). TO DATE, WE HAVE RECRUITED A RACIALLY AND ETHNICALLY DIVERSE SAMPLE OF WOMEN AT RISK FOR HYPERTENSIVE DISORDERS OF PREGNANCY, WITH >90% PARTICIPANT RETENTION, AND 89% OF PARTICIPANTS WHO COMPLETED THE PARENT STUDY REPORTED INTEREST IN PARTICIPATING IN THE PROPOSED ANCILLARY STUDY. HOWEVER, THE MOST SEVERE AND FATAL CARDIOVASCULAR COMPLICATIONS OCCUR IN THE POSTPARTUM PERIOD, AND IT IS NOT YET KNOWN WHETHER THE CARDIOVASCULAR BENEFITS OF PRENATAL MINDFULNESS TRAINING EXTEND INTO THE POSTPARTUM PERIOD. THUS, IN RESPONSE TO THE NOTICE OF SPECIAL INTEREST (NOSI): "HEART, LUNG, BLOOD AND SLEEP FOCUSED ANCILLARY STUDIES TO ONGOING CLINICAL STUDIES," WE PROPOSE TO TEST THE LONG-TERM EFFECTS OF PRENATAL MINDFULNESS TRAINING ON POSTPARTUM MECHANISMS OF RISK FOR MATERNAL AND INFANT CARDIOVASCULAR DISEASE. THE PROPOSED ANCILLARY STUDY WILL FOLLOW N=130 PARTICIPANTS AND INFANTS THAT ARE ENROLLED IN THE PARENT RCT ACROSS THE FIRST POSTPARTUM YEAR. AT 4-, 6-, AND 12-MONTHS POSTPARTUM, WE WILL MEASURE EFFECTS OF PRENATAL MINDFULNESS TRAINING ON: 1) POSTPARTUM MATERNAL CARDIOVASCULAR DISEASE BIOMARKERS, 2) POSTPARTUM PHYSIOLOGICAL AND PSYCHOLOGICAL RESPONSES TO ECOLOGICALLY VALID DAILY EXPERIENCES, AND 3) INFANT GROWTH TRAJECTORIES THAT CONFER RISK FOR LIFETIME CVD. RESULTS WILL HAVE A SIGNIFICANT IMPACT ON THE FIELD BY IDENTIFYING MODIFIABLE MECHANISMS IN THE PRE AND POSTNATAL PERIODS TO REDUCE RATES OF HYPERTENSIVE DISORDERS AND DECREASE LIFELONG BURDEN OF CVD IN WOMEN AND THEIR OFFSPRING. CONSISTENT WITH NHLBI'S OBJECTIVES, RESULTS FROM THIS STUDY WILL HELP TO DEVELOP AND OPTIMIZE NOVEL THERAPEUTIC STRATEGIES TO PREVENT HEART, LUNG, AND BLOOD DISEASES IN WOMEN AND INFANTS.

Posted 5/3/24, 12:00 AM